Generic Name and Formulations:
Tretinoin 0.025%; crm; gel.
Indications for AVITA:
Apply sparingly to cleansed and completely dry skin once daily at bedtime. If irritation develops, may reduce the dosing frequency.
Not for use in eczema or on sunburned skin. Minimize exposure to sun, UV light, weather extremes. Avoid eyes, mouth, angles of nose, mucous membranes. Pregnancy (Cat.C): not recommended. Nursing mothers.
Allow effects of benzoyl peroxide, sulfur, resorcinol, salicylic acid, other topical acne agents to subside before applying. Avoid keratolytics, abrasives, astringents, drying agents, high-alcohol content topical products, spices, lime.
Apparent exacerbation of symptoms, local skin reactions (including erythema, edema, blistering, crusting), transient pigmentation changes, stinging on application, dry skin.
Crm, gel—20g, 45g
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Purpose, Questions of Social Interaction Lead Physicians to Delay Retirement
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV
- Maintenance rTMS for Treatment-Resistant Depression
- New Study Compares Opioid Dependence Relapse Treatments
- Increase Use of Nursing Home for Patients With Cognitive Impairment Category
- Venlafaxine XR Safe, Effective in Treating Generalized Anxiety Disorder